MedDataX Logo

A Registry of Peripartum Cardiomyopathy in Turkey

NCT ID: NCT03364140

Last Updated: 2017-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-02

Study Completion Date

2018-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in centres in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

The objectives of the study are:

To define the clinical status and clinical characteristics of PPCM in Turkey

To define the outcome of PPCM (short and long term)

To define the demographical and possible etiological factors

To define prognostic factors

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripartum Cardiomyopathy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Peripartum Cardiomyopathy Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient above 18 years of age
* Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
* Ejection fraction less than 45% documented with echocardiography

Exclusion Criteria

* Patients with any other known cardiac pathology
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Turkish Society of Cardiology

OTHER

Sponsor Role collaborator

Ege University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Meral Kayikcioglu

Prof Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dilek Ural, MD

Role: STUDY_DIRECTOR

Koc University Medical school

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Koc University Medical School Cardiology Department

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Meral Kayikcioglu, MD

Role: CONTACT

Phone: +902323905448

Email: [email protected]

Meral Kayikcioglu

Role: CONTACT

Phone: +902323905448

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dilek Ural, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TKD-PPKM

Identifier Type: -

Identifier Source: org_study_id